Case Control Study
Copyright ©The Author(s) 2020.
World J Clin Cases. Jun 6, 2020; 8(11): 2144-2149
Published online Jun 6, 2020. doi: 10.12998/wjcc.v8.i11.2144
Table 1 Kidney function before and after treatment (mmol/L)
GroupSerum creatinine
Blood urea nitrogen
Before treatmentAfter treatmentBefore treatmentAfter treatment
Control560.25 ± 101.36511.34 ± 67.3225.45 ± 5.4222.56 ± 5.43
Study561.42 ± 100.58301.45 ± 51.2325.22 ± 5.2314.45 ± 3.32
t-0.04714.2530.1757.320
P value0.9630.0000.8610.000
Table 2 Serotoxin levels in the two groups
GroupParathyroid hormone (pg/mL)β2-microglobulin (mg/L)Serum cystatin C (mg/L)Blood urea nitrogen (mmol/L)
Control526.54 ± 20.6510.54 ± 1.693.58 ± 0.3620.46 ± 3.25
Study412.42 ± 13.4210.43 ± 1.682.21 ± 0.2320.54 ± 3.16
t26.6190.26518.422-0.101
P value0.0000.7920.0000.920
Table 3 Complications in the two groups, n (%)
GroupFatigueMuscle spasmItchy skinJoint painOverall incidence
Control12317 (20.00)
Study11103 (8.57)
χ2----5.335
P value----0.021